First-in-class analytical solution quickly detects intended and unintended edits in engineered cells at single-cell resolution, enabling safer therapies and better disease modeling SOUTH SAN FRANCISCO, Calif. – Mission Bio, a leader in single-cell multi-omic solutions for precision medicine, today launched the Tapestri® Genome Editing Solution. Designed to meet the pressing need for high-resolution analysis of genome […]
MANASSAS, Virginia and BOSTON, Massachusetts — Ceres Nanosciences, a global leader in developing wastewater testing methods based on its Nanotrap® technology, and Ginkgo Bioworks (NYSE: DNA), which is building the leading platform for cell programming and biosecurity, today announced that they are partnering to bring pathogen monitoring capabilities to laboratories around the world. Pathogen monitoring […]
AMSBIO has supplied a custom monoclonal antibody (mAB) to researchers at the TU Dortmund** in Germany to unravel the role of EDI3 in breast cancer development, its regulation by HER2 signalling, and its potential as a therapeutic target. Characterized by the overexpression of the Human Epidermal growth factor Receptor 2 (HER2) – HER2+ breast cancer is a highly aggressive disease […]
WATERTOWN, Mass. — Fluent BioSciences, a cutting edge life sciences company leading the charge in revolutionizing single cell analysis through simple, cost-effective, and highly scalable single-cell RNA sequencing solutions is thrilled to announce the award of an NIH Small Business Innovation Research (SBIR) Phase II grant, funded by the National Institute of General Medical Sciences […]
Resolution Bioscience’s blood-based diagnostic tests complement Exact Sciences’ Precision Oncology portfolio, providing a more complete cancer treatment solution for patients, healthcare professionals, and biopharma partners SANTA CLARA, Calif. & MADISON, Wis. — Agilent Technologies, Inc. (NYSE: A) and Exact Sciences Corp. (Nasdaq: EXAS), a leading provider of cancer screening and diagnostic tests, today announced they […]
New Program Expands Access to PacBio’s Highly Accurate Sequencing Systems by Providing Flexible Financing MENLO PARK, Calif. — PacBio (NASDAQ: PACB), a leading developer of high-quality, highly accurate sequencing solutions, today announced PacBio Capital, a program that offers customers the ability to lease PacBio sequencing systems – Revio, Onso and Sequel IIe – easily and cost-effectively. […]
Oberkochen, Germany — After more than 20 years at ZEISS, the Chief Financial Officer (CFO) of Carl Zeiss AG, Dr. Christian Müller, has decided not to extend his contract for another term. He has informed the Supervisory Board and will leave the company at his own request on 30 September 2023. “ZEISS continues its dynamic, […]
InSphero and Darwin Microfluidics signed distribution agreement to facilitate purchasing InSphero’s 3D in vitro products within the European Union Zurich, Switzerland – InSphero today announced that the company is making their 3D in vitro products available to researchers in the European Union market more easily by signing a distribution agreement with Darwin Microfluidics, an innovative startup dedicated to bringing advanced microfluidic solutions […]
A major bottleneck in drug discovery, particularly when targeting transmembrane proteins such as G-coupled receptor proteins (GPCRs), is the challenge of replicating in vitro the precise microenvironment conditions found inside a cell. These conditions are essential for maintaining the native conformation and normal activity of these proteins. To address this critical issue, Celtarys and G.CLIPS are thrilled […]
At Stratedigm, our vision has always been to build lasting flow cytometers and nurture lasting partnerships. Today, we are excited to introduce our newest customer care program. Named Flowraissance™ (FLOW-rah-sahns) in the spirit of the ideals of revival, exploration, and intellectual and scientific progress, the program aims to breathe new life into your trusted S1000 flow cytometer, empowering you […]
Pay Invoice
Latest Blogs
-
SDi Predicts a Recovery Amid Headwinds
July 24, 2026 2:51 pm
-
EU Roadmap Provides Further Impetus for New Approach Methodologies
June 29, 2026 12:56 pm
-
MOBILion Expands into Proteomics MS Market
April 30, 2026 5:05 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.
